Zolpidem Tartrate (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 01)
Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71335-2764
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71335-2764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Im-2 (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 02)
This is a chart showing zolpidem plasma concentrations (ng/mL) over time for two formulations of the drug: 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate release. The concentrations are measured at various time points from 0 to 8 hours. This data can be used to evaluate the pharmacokinetics of these formulations of zolpidem.*
Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 304 1)
Image (39503a0f Bbf2 4bb4 Ab5d 118d2e3b5bbf 334 1)
Label (Lbl713352764)
This is the description based on the provided text: Each film-coated tablet contains Zolpidem Tartrate. The adult dosage is one tablet at bedtime as directed. The package insert can be scanned for extended-release information. It is advised to dispense the medication guide to each patient in a tight, light-resistant, child-resistant container. The medication should be stored at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The manufacturer is Bryant Ranch Prepack, Inc. Lupin Limited. Remember to keep this and all drugs out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
